Lebsanft H B, Mayerhofer A, Kovar K-A, Schmidt W J
Neuropharmacology Institute, University of Tübingen, Germany.
J Neural Transm (Vienna). 2003 Jul;110(7):707-18. doi: 10.1007/s00702-003-0823-y.
3,4-Methylenedioxymethamphetamine (MDMA) has recently been hypothesized to be effective against the symptoms of Parkinson's disease. Therefore we tested the effects of MDMA-derivatives in the rotational behavioural model. Male Sprague Dawley rats were lesioned unilaterally with 6-hydroxydopamine at the medial forebrain bundle. MDMA was administered at doses of 2.5, 5.0 and 10.0 mg/kg, its derivatives N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butananamine (MBDB), 3,4-Methylenedioxy-N-ethylamphetamine (MDE) and 3,4-Methylenedioxyamphetamine (MDA) at 5.0 mg/kg respectively. All substances induced ipsilateral rotations, MDA being the most effective. MDMA induced rotations were attenuated by the selective serotonin reuptake inhibitor Citalopram but were only slightly reduced by pre-treatment with the selective serotonin synthesis inhibitor PCPA (para-chlorophenylalanine). The effects of MDMA can therefore not fully be explained by serotonin release or by dopaminergic activity of the drugs.
3,4-亚甲基二氧甲基苯丙胺(摇头丸)最近被推测对帕金森病症状有效。因此,我们在旋转行为模型中测试了摇头丸衍生物的效果。雄性斯普拉格-道利大鼠在内侧前脑束用6-羟基多巴胺进行单侧损伤。分别以2.5、5.0和10.0mg/kg的剂量给予摇头丸,其衍生物N-甲基-1-(1,3-苯并二氧杂环戊烯-5-基)-2-丁胺(MBDB)、3,4-亚甲基二氧-N-乙基苯丙胺(MDE)和3,4-亚甲基二氧苯丙胺(MDA)的剂量均为5.0mg/kg。所有物质均诱导同侧旋转,MDA最为有效。摇头丸诱导的旋转被选择性5-羟色胺再摄取抑制剂西酞普兰减弱,但用选择性5-羟色胺合成抑制剂对氯苯丙氨酸预处理仅使其略有降低。因此,摇头丸的作用不能完全用5-羟色胺释放或药物的多巴胺能活性来解释。